Nuclear Medicine & Radio Pharmaceuticals Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Nuclear Medicine & Radio Pharmaceuticals market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.6% during the forecast period.
This report presents the market size and development trends by detailing the Nuclear Medicine & Radio Pharmaceuticals market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Nuclear Medicine & Radio Pharmaceuticals market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Nuclear Medicine & Radio Pharmaceuticals industry and will help you to build a panoramic view of the industrial development.
Nuclear Medicine & Radio Pharmaceuticals Market, By Type:
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Nuclear Medicine & Radio Pharmaceuticals Market, By Application:
End-User 1
End-User 2
End-User 3
Some of the leading players are as follows:
Hitachi
Biosensors International Group, Ltd
Toshiba
Esaote
TriFoil Imaging
Philips Healthcare
Siemens Healthcare
Carestream
GE Healthcare
Shimadzu
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Nuclear Medicine & Radio Pharmaceuticals Market: Technology Type Analysis
-
4.1 Nuclear Medicine & Radio Pharmaceuticals Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Nuclear Medicine & Radio Pharmaceuticals Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
4.3.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
5 Nuclear Medicine & Radio Pharmaceuticals Market: Product Analysis
-
5.1 Nuclear Medicine & Radio Pharmaceuticals Product Market Share Analysis, 2018 & 2026
-
5.2 Nuclear Medicine & Radio Pharmaceuticals Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Nuclear Medicine & Radio Pharmaceuticals Market: Application Analysis
-
6.1 Nuclear Medicine & Radio Pharmaceuticals Application Market Share Analysis, 2018 & 2026
-
6.2 Nuclear Medicine & Radio Pharmaceuticals Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 End-User 1
6.3.2 End-User 1
6.3.3 End-User 3
7 Nuclear Medicine & Radio Pharmaceuticals Market: Regional Analysis
-
7.1 Nuclear Medicine & Radio Pharmaceuticals Regional Market Share Analysis, 2018 & 2026
-
7.2 Nuclear Medicine & Radio Pharmaceuticals Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Hitachi
9.1.1 Hitachi Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Biosensors International Group, Ltd
9.2.1 Biosensors International Group, Ltd Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Toshiba
9.3.1 Toshiba Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Esaote
9.4.1 Esaote Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 TriFoil Imaging
9.5.1 TriFoil Imaging Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Philips Healthcare
9.6.1 Philips Healthcare Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Siemens Healthcare
9.7.1 Siemens Healthcare Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Carestream
9.8.1 Carestream Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 GE Healthcare
9.9.1 GE Healthcare Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Shimadzu
9.10.1 Shimadzu Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 94 Figures and 160 Tables)
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Nuclear Medicine & Radio Pharmaceuticals market, 2015 - 2026 (USD Million)
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Nuclear Medicine & Radio Pharmaceuticals market, 2015 - 2026 (USD Million)
Figure End-User 1 market, 2015 - 2026 (USD Million)
Figure End-User 2 market, 2015 - 2026 (USD Million)
Figure End-User 3 market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Nuclear Medicine & Radio Pharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table North America Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table North America Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table North America Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Canada Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Canada Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Europe Nuclear Medicine & Radio Pharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table Europe Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Europe Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Europe Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Germany Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Germany Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table France Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table France Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Italy Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Italy Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Spain Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Spain Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table China Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table China Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Japan Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Japan Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table India Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table India Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Nuclear Medicine & Radio Pharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table MEA Nuclear Medicine & Radio Pharmaceuticals market, by country, 2015 - 2026 (USD Million)
-
Table MEA Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table MEA Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table MEA Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Nuclear Medicine & Radio Pharmaceuticals market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Nuclear Medicine & Radio Pharmaceuticals market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Nuclear Medicine & Radio Pharmaceuticals market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Hitachi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biosensors International Group, Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Toshiba Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Esaote Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table TriFoil Imaging Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Philips Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Siemens Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Carestream Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shimadzu Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis